NCT04520815

Brief Summary

Acute respiratory distress (ARD) is one of the most frequent reasons for consultation and hospitalization in emergency medicine. The use of ultrasound methods as a diagnostic and clinical assessment tool in emergency medicine is increasingly important. As such, ultrasound is a simple, non-invasive means of assessing diaphragmatic function in the patient's bed. Several methods of ultrasound assessment of diaphragm function have been described. Among these different methods, the diaphragmatic excursion seems to have a better intra and interobserver reproducibility as well as a greater feasibility, in particular because of its speed of realization and its learning curve seeming faster in comparison with the measurement. of the thickening fraction. Measuring the diaphragmatic excursion could therefore ultimately represent a simple means of assessing respiratory function, both diagnostic and prognostic, in patients with acute respiratory distress in the emergency departments. The etiologies of acute respiratory distress in very elderly patients (i.e.\> 75 years) admitted to the emergency reception service are multiple. To our knowledge, there is no data available in the literature on the prevalence of diaphragmatic dysfunction and its short- and long-term course in this category of patients. The main objective of this study is therefore to assess the prevalence of diaphragmatic dysfunction and its evolutionary kinetics in patients over the age of 75 admitted for acute respiratory distress in the emergency medicine department.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

June 24, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 20, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

October 6, 2021

Status Verified

October 1, 2021

Enrollment Period

1.5 years

First QC Date

June 24, 2020

Last Update Submit

October 5, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Presence of diaphragmatic dysfunction

    Ultrasound measurement of diaphragmatic excursion (ED)

    inclusion

  • Presence of diaphragmatic dysfunction

    Ultrasound measurement of diaphragmatic excursion (ED)

    Day 1

  • Presence of diaphragmatic dysfunction

    Ultrasound measurement of diaphragmatic excursion (ED)

    Day 3

  • Presence of diaphragmatic dysfunction

    Ultrasound measurement of diaphragmatic excursion (ED)

    Day 7

  • Presence of diaphragmatic dysfunction

    Ultrasound measurement of diaphragmatic excursion (ED)

    up to 7 days

Secondary Outcomes (13)

  • Inter-observer reproductibility of the measurement of ED and EIT

    Day 0

  • Predictive value of the presence of diaphragmatic dysfunction

    48 hours after the beginning of hospitalization

  • Predictive value of the presence of diaphragmatic dysfunction over the average length of hospital stay

    up to 7 days

  • Predictive value of the presence of a diaphragmatic dysfunction on mortality

    up to 7 days

  • Predictive value of the presence of a diaphragmatic dysfunction on mortality

    6 months after the end of hospitalization

  • +8 more secondary outcomes

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Recruitment of all patients over the age of 75, presenting to adult emergency departments and in spontaneous ventilation and having at least one criterion of acute respiratory distress.

You may qualify if:

  • Patient in spontaneous ventilation at the admission on emergency room
  • Presence of acute respiratory distress defined by at least 1 of the following criteria:
  • Respiratory rate \> 25/min and/or clinical signs of acute respiratory distress,
  • Hypoxia defined by Sp02 \< 90 %,
  • Hypercapnia defined by PaC02 \> 45 mmHg with respiratory acidosis defined by a pH value \<7.35.
  • Absence of opposition of the patient to his participation in the study and the use of his data or the trusted person if the state of the patient does not allow it.

You may not qualify if:

  • Presence of a preexisting diaphragmatic dysfunction appearing in the history or the medical file of the patient and explored on the electro-physiological level,
  • Patient with acute respiratory distress on arrival at the SAU with clinical criteria justifying immediate use of invasive mechanical ventilation and not allowing ultrasound measurements to be carried out or patient admitted to the SAU with mechanical ventilatory support from the outset,
  • Poor command of the French language or state incompatible with the patient's understanding and / or informed adherence to the study protocol,
  • History of surgery involving the integrity of the diaphragmatic muscle (diaphragm plication or diaphragmatic lumpectomy or placement of diaphragmatic pacemaker),
  • Criteria for shock or severe hemodynamic instability,
  • Intra-cranial hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de la Réunion

Saint-Denis, 97400, France

RECRUITING

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Thomas GROSEIL, Dr

    CHU de La Réunion

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2020

First Posted

August 20, 2020

Study Start

June 24, 2020

Primary Completion

December 31, 2021

Study Completion

June 30, 2022

Last Updated

October 6, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations